It takes almost a decade to develop a new medicine but Moncef Slaoui hopes to inject a profound cultural change in a far shorter time to speed up successful drug development at Glaxo.

More than a year after he was appointed to oversee the pharmaceutical group’s entire pipeline of future products, Mr Slaoui is bringing the benefits of his long professional experience with vaccines to the broader area of medicines research.